Related Experiment Video

Updated: Oct 14, 2025

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
09:13

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy

Published on: November 1, 2011

17.6K

Pityriasis Rosea Shortly After mRNA-1273 COVID-19 Vaccination

Sun Hye Shin1, Jun Ki Hong1, Soon Auck Hong2

  • 1Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Korea.

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|November 6, 2021
PubMed
Abstract

No abstract available in PubMed .

Keywords:
COVID-19Pityriasis roseaVaccinationmRNA-1273

More Related Videos

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

43.1K
Using Click Chemistry to Measure the Effect of Viral Infection on Host-Cell RNA Synthesis09:35

Using Click Chemistry to Measure the Effect of Viral Infection on Host-Cell RNA Synthesis

Published on: August 9, 2013

11.9K

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.6K
Cross-reactivity00:42

Cross-reactivity

Overview
31.8K